度洛西汀
普瑞巴林
纤维肌痛
医学
阿米替林
米尔纳奇普兰
内科学
随机对照试验
不利影响
中止
药理学
麻醉
抗抑郁药
替代医学
病理
海马体
作者
H Farag,Ismaeel Yunusa,Hardik Goswami,Ihtisham Sultan,Joanne Doucette,Tewodros Eguale
出处
期刊:JAMA network open
[American Medical Association]
日期:2022-05-19
卷期号:5 (5): e2212939-e2212939
被引量:54
标识
DOI:10.1001/jamanetworkopen.2022.12939
摘要
Amitriptyline is an established medication used off-label for the treatment of fibromyalgia, but pregabalin, duloxetine, and milnacipran are the only pharmacological agents approved by the US Food and Drug Administration (FDA) to treat fibromyalgia.
科研通智能强力驱动
Strongly Powered by AbleSci AI